**3. Conclusion and future perspectives**

Despite the current recognition of *Copernicia prunifera* as a quintessential Brazilian plant with growing interest of research and a boost in its commerce and industrial application for the formulation of therapeutic products, it can be safely postulated that its therapeutic potentials have not been fully explored. At present, researches and commercial interest on carnauba wax are skewed toward its cosmeceutical, food and pharmaceutical applications which have dwarfed research interest in its potential as a remedy for other diseases. Thus, further researches on its pharmacological activity recommended with the end-goal of unraveling the pharmacodynamics, pharmacokinetics and clinical relevance. In addition, toxicity risk assessment studies of both the bioactive extracts and isolated constituents need to be given more attention. Nevertheless, further studies and long-term human trials should be carried out in order to clarify the relationship between the consumption of 4-methoxy cinnamic acid diesters and its derivatives such as isolated pectin and their benefic impact on the human body, there seems to be certainly a promising future for new investigations.
